These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Tyrosine phosphorylation of NEDD4 activates its ubiquitin ligase activity. Persaud A; Alberts P; Mari S; Tong J; Murchie R; Maspero E; Safi F; Moran MF; Polo S; Rotin D Sci Signal; 2014 Oct; 7(346):ra95. PubMed ID: 25292214 [TBL] [Abstract][Full Text] [Related]
9. Illuminating the molecular mechanisms of tyrosine kinase inhibitor resistance for the FGFR1 gatekeeper mutation: the Achilles' heel of targeted therapy. Sohl CD; Ryan MR; Luo B; Frey KM; Anderson KS ACS Chem Biol; 2015 May; 10(5):1319-29. PubMed ID: 25686244 [TBL] [Abstract][Full Text] [Related]
10. Molecular basis for receptor tyrosine kinase A-loop tyrosine transphosphorylation. Chen L; Marsiglia WM; Chen H; Katigbak J; Erdjument-Bromage H; Kemble DJ; Fu L; Ma J; Sun G; Zhang Y; Liang G; Neubert TA; Li X; Traaseth NJ; Mohammadi M Nat Chem Biol; 2020 Mar; 16(3):267-277. PubMed ID: 31959966 [TBL] [Abstract][Full Text] [Related]
11. Autophosphorylation of FGFR1 kinase is mediated by a sequential and precisely ordered reaction. Furdui CM; Lew ED; Schlessinger J; Anderson KS Mol Cell; 2006 Mar; 21(5):711-7. PubMed ID: 16507368 [TBL] [Abstract][Full Text] [Related]
12. The precise sequence of FGF receptor autophosphorylation is kinetically driven and is disrupted by oncogenic mutations. Lew ED; Furdui CM; Anderson KS; Schlessinger J Sci Signal; 2009 Feb; 2(58):ra6. PubMed ID: 19224897 [TBL] [Abstract][Full Text] [Related]
13. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform. Gonçalves C; Bastos M; Pignatelli D; Borges T; Aragüés JM; Fonseca F; Pereira BD; Socorro S; Lemos MC Fertil Steril; 2015 Nov; 104(5):1261-7.e1. PubMed ID: 26277103 [TBL] [Abstract][Full Text] [Related]
14. Extended Synaptotagmin Interaction with the Fibroblast Growth Factor Receptor Depends on Receptor Conformation, Not Catalytic Activity. Tremblay MG; Herdman C; Guillou F; Mishra PK; Baril J; Bellenfant S; Moss T J Biol Chem; 2015 Jun; 290(26):16142-56. PubMed ID: 25922075 [TBL] [Abstract][Full Text] [Related]
15. Structural insights into the interaction of human S100B and basic fibroblast growth factor (FGF2): Effects on FGFR1 receptor signaling. Gupta AA; Chou RH; Li H; Yang LW; Yu C Biochim Biophys Acta; 2013 Dec; 1834(12):2606-19. PubMed ID: 24063890 [TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain. Lee CC; Jia Y; Li N; Sun X; Ng K; Ambing E; Gao MY; Hua S; Chen C; Kim S; Michellys PY; Lesley SA; Harris JL; Spraggon G Biochem J; 2010 Sep; 430(3):425-37. PubMed ID: 20632993 [TBL] [Abstract][Full Text] [Related]
17. RSK2 regulates endocytosis of FGF receptor 1 by phosphorylation on serine 789. Nadratowska-Wesolowska B; Haugsten EM; Zakrzewska M; Jakimowicz P; Zhen Y; Pajdzik D; Wesche J; Wiedlocha A Oncogene; 2014 Oct; 33(40):4823-36. PubMed ID: 24141780 [TBL] [Abstract][Full Text] [Related]
18. Disease-causing mutation in extracellular and intracellular domain of FGFR1 protein: computational approach. Rajith B; George Priya Doss C Appl Biochem Biotechnol; 2013 Mar; 169(5):1659-71. PubMed ID: 23329143 [TBL] [Abstract][Full Text] [Related]